Aicore Life Sciences is an R&D focused pharmaceutical company with headquarters based in the Netherlands. Its founders share a common background as employees of Organon, which was the pharmaceutical division of AKZO before it became a part of Schering Plough and subsequently Merck & Co. Organon was a market leader in women’s health and stood at the forefront of many important developments in this market segment.
We are developing a product portfolio consisting of both affordable generics and new chemical entities/new dosage forms. We are focusing particularly on European countries, with emphasis on women’s health. Our network encompasses the complete range of facilities required for all stages of drug development, distribution, marketing and sales across the European continent, and includes partnerships with academia. This considerably simplifies and shortens the complicated path from idea to drug store.
Aicore Life Sciences welcomes partners to join its business in the different stages of development and to benefit from products in market niches which we consider insufficiently served.
Aicore Life Sciences welcomes partners providing services or participating in the risks and benefits of the business. We have the advantage of embracing the whole process of drug development from early and pre-clinical phases, to promoting a product on the pharmacy’s shelf. This sets us apart from many other companies operating in the same field.